Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Bienengiftsalbe (Bee Venom Ointment) is a topical pharmaceutical product containing bee venom (apitoxin) derived from the honeybee, *Apis mellifera*. Marketed by medphano Arzneimittel, it is indicated for the symptomatic treatment of various musculoskeletal conditions, including rheumatic diseases, arthrosis, and muscle or joint pain. The therapeutic efficacy of the ointment is attributed to the complex mixture of peptides (such as melittin and apamin) and enzymes (such as phospholipase A2) found in bee venom. These components exert anti-inflammatory, analgesic, and rubefacient effects; the latter increases local blood flow to the application site, which helps to reduce pain and promote healing in the underlying tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on bee venom.